Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of Candidemia and Invasive Candidiasis.
Melinta Therapeutics came to Modality Solutions for cold chain support, and our experts conducted a root cause failure analysis and recommended an improved packaging strategy.
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
